Article
Citizens Downgrades Quince Therapeutics to Market Perform
Citizens analyst Jonathan Wolleben downgrades Quince Therapeutics (NASDAQ:QNCX) from Market Outperform to Market Perform.
Comments
- No comments yet. Be the first to comment!